Max India Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Finance | Market Cap: ₹905 Cr
AGEasy aims to double its revenue from INR77 crores to approximately INR150 crores in FY27, with July monthly run rate already at INR10 crores and an ARR trending towards INR120 crores. Company expects a path to profitability across businesses within the next 2 quarters.
From Max India Ltd's Q1 FY27 earnings-call transcript · updated 26 Aug 2026.
Price
₹151
Market Cap
₹905 Cr
Revenue Rank
Margin Rank
How does Max India Ltd rank in Finance?
Compare Max India Ltd against every Finance company this quarter on revenue, margins and earnings-call signals.
Max India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹66 Cr, net profit ₹-19 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →AGEasy aims to double its revenue from INR77 crores to approximately INR150 crores in FY27, with July monthly run rate already at INR10 crores and an ARR trending towards INR120 crores.
- →Significant growth spurts expected during festive seasons and winter, typical for senior care products.
- →Senior living residential sales targets around INR1,800 crores annually by 2030-33, with new projects in Bangalore (~300 units, INR900 crores sales value) and Dehradun (~150 units, INR850-900 crores sales value) in advanced stages.
- →Care Homes occupancy is improving steadily (e.g., Bannerghatta from 37% to 41%), with potential expansion plans in late FY27.
- →Overall revenue growth is expected across Care Homes and AGEasy, supported by rising occupancy, improving marketing efficiency (ROAS), and expanding product offerings.
- →Management confident of sustained growth trajectory with upcoming announcements and a focus on execution.
📈 Profitability & Margins
Rank 3- →Company expects a path to profitability across businesses within the next 2 quarters.
- →AGEasy aims for EBITDA breakeven by FY27's last quarter, with improving contribution margins and reduced losses (EBITDA losses dropped from 95% to 63%).
- →Care Homes expansion requires significant capital but expected to reach 23-24%+ ROCE; profitability at a unit level may take 8-10 quarters post-bed addition.
- →Senior living (ASL) aims for healthy annuity income with INR1,800 crores annual sales target by FY30/FY33.
- →Despite strong revenue growth, EBITDA losses have been reducing; trajectory expected to continue with revenue growth and contained losses.
- →Operational improvements like increased occupancy in Care Homes and improved return on advertising spend (ROAS) for AGEasy support earnings growth.
- →No new strategies planned; focus remains on execution to boost profitability.
- →Earnings inflection expected via increased top line in AGEasy and scaling Care Homes profitably with steady occupancy improvements.
🏗️ Capital Expenditure Plans
Yes- →The total capital requirement has come down slightly from about $25 million to under $20 million, with an estimated need of around $20 million over the next 2 years.
- →The initial capital raise was through two tranches of rights issues and preference shares; the second tranche of pref issue raised INR40 crores in July 2026.
- →No change in capital plans from two years ago; the company is utilizing credit lines to manage working capital and has delayed the second fund raise due to improved performance and collections from Noida possession.
- →Future capital deployment will be higher in Care Home expansion, as each bed requires INR10-12 lakhs capex, including operational losses.
- →Senior Living projects include upcoming launches such as approx. 300 units in North Bangalore (INR900 crores potential sales value) and about 150 units in Dehradun (INR850-900 crores potential), indicating ongoing strategic investments.
- →Focus remains on scalable execution and path to profitability rather than new strategies.
💰 Fundraising & Capital Structure
Yes- →No change in overall capital requirement from what was stated two years ago.
- →Initial capital raise was through two tranches of rights issue and preferential issue.
- →Second fund raise was initially planned for June but has been pushed out due to better performance and use of credit lines for working capital.
- →INR 40 crores received in the second tranche of the preferential issue in July.
- →Total capital needed has reduced from about $25 million to under $20 million.
- →The company is currently managing working capital and inventory via credit lines (debt).
- →Future capital raise plans remain aligned with previous targets, with around $20 million estimated incremental capital needed over next two years.
- →No new major fundraising announced yet; focus is on execution and cash flow from operations including collections from Noida project.
📋 Order Book & Pipeline
Yes- →Total collections since inception: INR 108.2 crores with approx. 194-197 units sold so far (Page 6).
- →Antara Assisted Care has a total bed capacity of 485 beds across 8 Care Homes in NCR, Bengaluru, and Chennai (Page 6).
- →Occupancy is gradually increasing, with several Care Homes showing improving trends in contribution margins and ARPOB (Average Revenue per Occupied Bed) exceeding INR 7,000 (Page 6).
- →New opportunities in pipeline:
- → - Bangalore project: About 300 units, potential sales value of ~INR 900 crores, in last stages of diligence (Page 4).
- → - Dehradun project: ~150 units, potential sales value of ~INR 850-900 crores, land identified (Page 4).
- →Ongoing dialogues for expansion in Chennai, Chandigarh, and Lucknow (Page 4).
- →The total sales value aimed from these new projects is approximately INR 1,800 crores, targeting a 1.5 million square feet total ambition (Page 4).
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
What Max India Ltd's management said in earlier quarters
Others in Finance this season
- Arman Financial (Q1 FY27)
Microfinance disbursements have shown strong performance, with Q4 reaching INR738 crores; infrastructure is sufficient to support INR700-750 crores quarterly…
- Finkurve Fin. (Q1 FY27)
AUM (Assets Under Management) grew strongly by ~135% YoY, driven equally by gold price appreciation (50%) and tonnage growth (50%). Key concall takeaways from…
- Religare Enterprises Ltd (Q1 FY27)
Broking business is in a repair and investment phase with intentions to build a new growth model; Q1 FY27 revenue increased 7% YoY with a 53% increase in PBT…
- Sammaan Capital Ltd (Q1 FY27)
Q1 disbursements approximately INR 3,900 crores. Key concall takeaways from Sammaan Capital Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Max India Ltd Q1 FY27 results?
AGEasy aims to double its revenue from INR77 crores to approximately INR150 crores in FY27, with July monthly run rate already at INR10 crores and an ARR trending towards INR120 crores. Company expects a path to profitability across businesses within the next 2 quarters.
What is Max India Ltd share price analysis?
Max India Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of N/A with a market cap of ₹905 Cr. Investors should review the full earnings analysis for detailed insights.
Is Max India Ltd planning capital expenditure?
The total capital requirement has come down slightly from about $25 million to under $20 million, with an estimated need of around $20 million over the next 2 years.
Keep Max India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.